Package 62135-947-90

Brand: repaglinide

Generic: repaglinide
NDC Package

Package Facts

Identity

Package NDC 62135-947-90
Digits Only 6213594790
Product NDC 62135-947
Product ID 62135-947_342983dc-ded9-2234-e063-6294a90ac97f
Description

90 TABLET in 1 BOTTLE (62135-947-90)

Marketing

Marketing Status
Marketed Since 2025-04-24
Brand repaglinide
Generic repaglinide
Sample Package No

Linked Drug Pages (1)

Repaglinide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "342983dc-ded9-2234-e063-6294a90ac97f", "openfda": {"nui": ["N0000175428", "N0000175448"], "upc": ["0362135948900", "0362135947903", "0362135946906"], "unii": ["668Z8C33LU"], "rxcui": ["200256", "200257", "200258"], "spl_set_id": ["cb995e92-295e-4638-a064-978211f5afe1"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (62135-947-90)", "package_ndc": "62135-947-90", "marketing_start_date": "20250424"}], "brand_name": "Repaglinide", "product_id": "62135-947_342983dc-ded9-2234-e063-6294a90ac97f", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "62135-947", "generic_name": "Repaglinide", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": "1 mg/1"}], "application_number": "ANDA078555", "marketing_category": "ANDA", "marketing_start_date": "20140122", "listing_expiration_date": "20261231"}